SABBY MANAGEMENT, LLC - ASLAN PHARMACEUTICALS LTD ownership

ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 38 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 42.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of ASLAN PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2022$126,252
-57.8%
350,700
-29.7%
0.11%
-70.6%
Q3 2022$299,000
-33.0%
499,045
-44.6%
0.38%
+24.4%
Q2 2022$446,000
-46.8%
900,000
-3.5%
0.30%
+142.4%
Q1 2022$839,000
-16.8%
932,399
+3.6%
0.12%
-15.0%
Q4 2021$1,008,000
-17.7%
899,850
+30.7%
0.15%
-11.4%
Q3 2021$1,225,000
-51.5%
688,400
-10.0%
0.17%
-53.4%
Q2 2021$2,525,000
-7.8%
765,276
-6.3%
0.36%
-33.2%
Q1 2021$2,738,000817,1650.53%
Other shareholders
ASLAN PHARMACEUTICALS LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,017,971$2,066,0000.49%
DAFNA Capital Management LLC 117,682$239,0000.08%
Temasek Holdings (Private) Ltd 1,422,475$2,888,0000.02%
PLATINUM INVESTMENT MANAGEMENT LTD 415,450$843,0000.02%
Virtu Financial LLC 54,386$110,0000.01%
MARSHALL WACE, LLP 96,095$195,0000.00%
UBS Group AG 150$00.00%
DEUTSCHE BANK AG\ 2,151$4,0000.00%
MORGAN STANLEY 18,582$37,0000.00%
BANK OF MONTREAL /CAN/ 10,000$20,0000.00%
View complete list of ASLAN PHARMACEUTICALS LTD shareholders